[Skip to Content]
[Skip to Content Landing]
Comment & Response
July 2018

Limitations of the National Cancer Data Base to Evaluate Early-Stage Anal Cancer Treatment Outcomes

Author Affiliations
  • 1Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland
JAMA Surg. 2018;153(7):690-691. doi:10.1001/jamasurg.2018.0391

To the Editor We read with interest the article by Chai et al,1 who performed a retrospective review of the National Cancer Data Base (NCDB) examining treatment for T1N0 squamous cell carcinoma of the anal canal and found that the overall survival was not different for those treated with local excision vs chemoradiotherapy. We congratulate the authors on their contribution to the trend in anorectal oncology questioning current treatment orthodoxy.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words